1-5 of 5
Hervé Dombret
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders

David Fandrei, Jean Pegliasco, Florence Pasquier, Nathalie Ibrahim, Maria Kfoury, Céline Berthon, Mael Heiblig, Delphine Lebon, Ambroise Marçais, Mathieu Meunier, Ahmad Al Jijakli, Emilie Lemasle, Sylvain Chantepie, Cecile Pautas, Pierre-Yves Dumas, Celia Salanoubat, Diana Carp, Romain Loyaux, Cyril Quivoron, Arnaud Pages, Bastien Job, Remy Jelin, Gerome Jules-Clement, Iléana Antony-Debré, Aline Renneville, Sophie Cotteret, Raphael Itzykson, Herve Dombret, Nicolas Duployez, Nathalie Droin, Alexandra Leary, Christophe Marzac, Elsa Bernard, Jean-Baptiste Micol
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF13.
https://doi.org/10.1158/1078-0432.CCR-24-3683
Published: 28 April 2025
View articletitled, Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders
Open the PDF for Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders in another window
Includes: Supplementary data
Journal Articles

PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax

Antoine Pinton, Lucien Courtois, Charlotte Doublet, Aurélie Cabannes-Hamy, Guillaume Andrieu, Charlotte Smith, Estelle Balducci, Agata Cieslak, Aurore Touzart, Mathieu Simonin, Véronique Lhéritier, Françoise Huguet, Marie Balsat, Hervé Dombret, Philippe Rousselot, Salvatore Spicuglia, Elizabeth Macintyre, Nicolas Boissel, Vahid Asnafi
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 94–105.
https://doi.org/10.1158/1078-0432.CCR-23-2159
Published: 05 January 2024
View articletitled, PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax
Open the PDF for PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax in another window
Includes: Supplementary data
Journal Articles

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience

Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Sarah Bertoli, Lauris Gastaud, Célestine Simand, Sylvain Chantepie, Madalina Uzunov, Alexis Genthon, Céline Berthon, Edmond Chiche, Pierre-Yves Dumas, Jacques Vargaftig, Géraldine Salmeron, Emilie Lemasle, Emmanuelle Tavernier, Jérémy Delage, Marion Loirat, Nadine Morineau, Félix Blanc-Durand, Patricia Pautier, Véronique Vergé, Nathalie Auger, Myrtille Thomas, Laetitia Stefani, Marion Lepelley, Thomas Boyer, Sylvain Thepot, Marie-Pierre Gourin, Pascal Bourquard, Matthieu Duchmann, Pierre-Marie Morice, Mauricette Michallet, Lionel Adès, Pierre Fenaux, Christian Récher, Hervé Dombret, Arnaud Pagès, Christophe Marzac, Alexandra Leary, Jean-Baptiste Micol, on behalf of UNIHEM, French Network of Pharmacovigilance Centers, ALFA, FILO, and GFM
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (23): 5211–5220.
https://doi.org/10.1158/1078-0432.CCR-22-1622
Published: 01 December 2022
View articletitled, Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience
Open the PDF for Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience in another window
Includes: Supplementary data
Journal Articles

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL

Aurore Touzart, Etienne Lengliné, Mehdi Latiri, Mohamed Belhocine, Charlotte Smith, Xavier Thomas, Salvatore Spicuglia, Denis Puthier, Françoise Pflumio, Thibaut Leguay, Carlos Graux, Yves Chalandon, Françoise Huguet, Stéphane Leprêtre, Norbert Ifrah, Hervé Dombret, Elizabeth Macintyre, Mathilde Hunault, Nicolas Boissel, Vahid Asnafi
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2483–2493.
https://doi.org/10.1158/1078-0432.CCR-18-1844
Published: 15 April 2019
View articletitled, Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL
Open the PDF for Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL in another window
Includes: Supplementary data
Journal Articles

T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome

Frederic Baleydier, Anne-Valerie Decouvelaere, Julie Bergeron, Philippe Gaulard, Danielle Canioni, Yves Bertrand, Stephane Lepretre, Barbara Petit, Herve Dombret, Kheira Beldjord, Thierry Molina, Vahid Asnafi, Elizabeth Macintyre
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 692–700.
https://doi.org/10.1158/1078-0432.CCR-07-1927
Published: 01 February 2008
View articletitled, T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome
Open the PDF for T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome in another window
Includes: Supplementary data